The Worst Drug Company Marketing Techniques (IV): BMS

In 2007, Bristol-Myers Squibb settled with the U.S. Department of Justice on a number charges, which included unlawful marketing of pharmaceuticals, illegal pricing, and offering kickbacks to health care providers. BMS allegedly promoted one of its drugs, the anti-psychotic Abilify, for unsanctioned use in treating dementia and children. As a result, the New York drug company was fined $515 million.

Ver anteriores...